Skip to content

Clinical trials

Recruiting Non-alcoholic Fatty Liver Disease trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Status: Recruiting Country / region: China Clear all

29 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20161
20171
20181
20202
20224
20234
20246
20255
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Recruiting29

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Friendship Hospital3
Humanity and Health Research Centre2
Beijing Municipal Administration of Hospitals1
Beijing Tsinghua Chang Gung Hospital1
Changchun Intellicrown Pharmaceutical Co. LTD1
Chia Tai Tianqing Pharmaceutical Group Nanjing Shunxin Pharmaceutical Co., Ltd.1
Eli Lilly and Company1
First Affiliated Hospital of Wenzhou Medical University1
Fujian Provincial Hospital1
Haisco Pharmaceutical Group Co., Ltd.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease29
Fatty Liver5
Fibrosis5
Hepatitis B, Chronic4
Carcinoma, Hepatocellular2
Liver Cirrhosis2
Obesity2
Acquired Immunodeficiency Syndrome1
Acute Lung Injury1
Diabetes Mellitus, Type 21

Trials

Showing 1 to 25 of 29. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.